Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

doi:10.1186/1756-8722-2-20

Journal of Hematology & Oncology

Volume 2

Viewing options:

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Raza A
Galili N
Callander N
Ochoa L
Piro L
Emanuel P
Williams S
Burris H
Faderl S
Estrov Z
Curtin P
Larson RA
Keck JG
Jones M
Meng L
Brown GL

on PubMed

Raza A
Galili N
Callander N
Ochoa L
Piro L
Emanuel P
Williams S
Burris H
Faderl S
Estrov Z
Curtin P
Larson RA
Keck JG
Jones M
Meng L
Brown GL
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Email this article to a friend

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra^®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

Azra Raza , Naomi Galili , Natalie Callander , Leonel Ochoa , Lawrence Piro , Peter Emanuel , Stephanie Williams , Howard Burris III , Stefan Faderl , Zeev Estrov , Peter Curtin , Richard A Larson , James G Keck , Marsha Jones , Lisa Meng and Gail L Brown

Journal of Hematology & Oncology 2009, 2:20doi:10.1186/1756-8722-2-20

Your name*
Your email address*
Recipient's email address*	(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:	I thought the following article from Journal of Hematology & Oncology (http://www.jhoonline.org/home) would be of interest to you.